Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 11Published on the World Wide Web on 27 November 1998.1-Reference-Cited by-同舟云学术

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 11Published on the World Wide Web on 27 November 1998.1

Published:1999-07 Issue:1 Volume:835 Page:1-9
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Contarino Angelo,Dellu Françoise,Koob George F.,Smith George W.,Lee Kuo-Fen,Vale Wylie,Gold Lisa H.

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference52 articles.

1. CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat;Baldwin;Psychopharmacology,1991

2. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders;Behan;Mol. Psychiatry,1996

3. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease;Behan;Nature,1995

4. CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice;Berridge;Pharmacol. Biochem. Behav.,1989

5. Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF;Britton;Life Sci.,1986

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The diverse role of corticotropin-releasing factor (CRF) and its CRF1 and CRF2 receptors under pathophysiological conditions: Insights into stress/anxiety, depression, and brain injury processes;Neuroscience & Biobehavioral Reviews;2024-08

2. Chronic interleukin-6 mediated neuroinflammation decreases anxiety, and impaires spatial memory in aged female mice;Frontiers in Neuroscience;2023-11-23

3. Windows into stress: a glimpse at emerging roles for CRH^PVN neurons;Physiological Reviews;2023-04-01

4. Changes in Corticotropin-Releasing Factor Receptor Type 1, Co-Expression with Tyrosine Hydroxylase and Oxytocin Neurons, and Anxiety-Like Behaviors across the Postpartum Period in Mice;Neuroendocrinology;2023

5. Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments;Advances in Clinical Chemistry;2023